home / stock / rcel / rcel news

RCEL News and Press, Avita Medical Inc. From 04/10/24

Stock Information
Company Name: Avita Medical Inc.
Stock Symbol: RCEL
Market: NYSE
Website: avitamedical.com
Menu
RCEL RCEL Quote RCEL Short RCEL News RCEL Articles RCEL Message Board
Get RCEL Alerts

News, Short Squeeze, Breakout and More Instantly...
RCEL - AVITA Medical lowers Q1 revenue outlook on slower conversion rate of new accounts

2024-04-10 17:27:45 ET More on AVITA Medical AVITA Medical: Unconvincing Growth Amid Fierce Competition In The Burn Care Sector AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript AVITA Medical Q4 2023 Earnings Preview Cantor picks RCEL as best 2024 m...
RCEL - AVITA Medical Updates Expected First Quarter 2024 Revenue

VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its expected commercial revenue for th...

RCEL - When (RCEL) Moves Investors should Listen

2024-04-04 08:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RCEL - (RCEL) Proactive Strategies

2024-03-25 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
RCEL - AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement

VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and D...

RCEL - AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference

VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that David O’Toole, Chief Financial Officer, ...

RCEL - AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript

2024-02-22 23:03:08 ET AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Conference Call February 22, 2024 04:30 PM ET Company Participants Jessica Ekeberg - Director, IR Jim Corbett - CEO David O'Toole - CFO Conference Call Participants Brooks O'Neil - Lak...
RCEL - AVITA Medical GAAP EPS of -$0.28 beats by $0.09, revenue of $14.2M beats by $0.17M

2024-02-22 16:30:39 ET More on AVITA Medical AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum AVITA Medical Q4 2023 Earnings Preview Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS Seeking Alpha’s ...

RCEL - AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the fourth quarter and full-yea...

RCEL - AVITA Medical Q4 2023 Earnings Preview

2024-02-21 12:16:33 ET More on AVITA Medical AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS Avita Medical misses Q4, FY23 prelim revenue estimate Seeking ...
Previous 10 Next 10